Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3744586 | 0.84 | HTR6 (0.66) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3750584 | 0.81 | HTR6 (0.90) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3755474 | 0.80 | HTR6 (0.88) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3749657 | 0.79 | HTR6 (0.63) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3748730 | 0.79 | HTR6 (0.90) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3752792 | 0.79 | HTR6 (0.88) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3747658 | 0.79 | HTR6 (0.64) | HTR6 | |
| SCHEMBL3746680 | 0.78 | HTR6 (0.67) | HTR6 | |
| SCHEMBL7049889 | 0.78 | HTR6 (1.00) | HTR6 | |
| Trifluoroacetic Acid SCHEMBL3754769 | 0.78 | HTR6 (0.93) | HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7838518-B2 | 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders | N.V. ORGANON (NL) | 2010-11-23 | — | — | US | disclosed |
| US-20050154023-A1 | 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders | MERCK SHARP & DOHME B.V. (NL) | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154023-A1 | 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders | TPH1, HTR1A, HTR1D | HTR6 12/4885POLB 3976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.